Two Sigma Securities, LLC Vericel Corp Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$10.77 - $18.44 $121,334 - $207,745
-11,266 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$9.1 - $14.8 $102,520 - $166,736
11,266 New
11,266 $159,000
Q1 2018

May 15, 2018
SELL
$5.7 - $12.3 $75,279 - $162,446
-13,207 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$3.65 - $5.98 $48,205 - $78,977
13,207
13,207 $72,000

Others Institutions Holding VCEL

# of Institutions
275
Shares Held
48.4M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email